Silvernail Lauren P
SEC-identified person · CIK 1225755 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Transdel Pharmaceuticals INC TDLP.OB | Director | filed 2024–2026 |
| Dynavax Technologies Corp dvax | Director | filed 2025–2026 |
| Harpoon Therapeutics, Inc. HARP | Director | filed 2022–2024 |
| Evolus, Inc. EOLS) | See Remarks | filed 2018–2022 |
| Revance Therapeutics, Inc. RVNC | CFO, Seretary & EVP Corp Dev. | filed 2014–2018 |
| Ista Pharmaceuticals INC ISTA | Chief Financial Officer | filed 2006–2012 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.